Trump Effect: Reputational Risk For D&Os

In just one week, President Trump told America that pharmaceutical companies were “getting away with murder,” sending their stocks plummeting before meeting with industry CEOs and their stocks rebounding. Within the same timeframe, Trump said he’d eliminate 75% to 80% of FDA regulations to bring pharma manufacturing jobs back to the US. All of this may be music to the ears of Trump supporters, but for directors and officers (D&Os) this type of talk creates risk, according to a reputation insurer.